As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
AABB to Present on CGT Quality Gaps at Meeting on the Mesa
September 08, 2026
AABB Accepting Lightning Talk Proposals for Cord Blood Connect 2026 Through Tuesday
September 02, 2026
New CTMC Review Highlights Key Advances in Transfusion Medicine and Biotherapies From 2025
September 01, 2026